Ye Shen
Ye Shen publishes mostly in Molecular Biology, Oncology and Surgery, on topics such as Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders and Chronic Lymphocytic Leukemia Research.
- World rank
- #5,503,641 of 7,710,434 ranked researchers
- Rank in China
- #801,286 of 978,568
- Works
- 52
- Citations
- 519
- Citations per work
- 10.0
What does Ye Shen research?
Ye Shen's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2853.2%
- Health Sciences1936.9%
- Medicine1936.9%
- Life Sciences59.9%
- 1Molecular Biology10% of their works
- 2Oncology10% of their works
- 3Surgery8% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Hematology5% of their works
Research topics
- Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Chronic Lymphocytic Leukemia Research
- Pharmaceutical Practices and Patient Outcomes
- COVID-19 Clinical Research Studies
- Cancer-related molecular mechanisms research
- Epigenetics and DNA Methylation
- Retinoids in leukemia and cellular processes
Which keywords describe Ye Shen's research?
The keywords of their largest research topics: Rituximab, Classification, Lymphoma, Epstein-Barr Virus, Kaposi's Sarcoma, Chronic Lymphocytic Leukemia, Clinical Characteristics and Genomic Aberrations.
- Long Noncoding RNAs
- DNA Methylation
- Acute Promyelocytic Leukemia
- Polypharmacy
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Epstein-Barr Virus
- Classification
- Rituximab
- Lymphoma
- Kaposi's Sarcoma
- Clinical Characteristics
- Inappropriate Medication Use
- SARS-CoV-2
- Cancer
- Histone Modification
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Rituximab102 topics
- Classification71 topic
- Lymphoma71 topic
- Epstein-Barr Virus41 topic
- Kaposi's Sarcoma41 topic
- Chronic Lymphocytic Leukemia31 topic
- Clinical Characteristics31 topic
- Genomic Aberrations31 topic
- Inappropriate Medication Use31 topic
- Polypharmacy31 topic
- SARS-CoV-231 topic
- Acute Promyelocytic Leukemia21 topic
- Cancer21 topic
- DNA Methylation21 topic
- Histone Modification21 topic
- Long Noncoding RNAs21 topic
- Retinoic Acid21 topic
Where does Ye Shen work?
Ye Shen's main affiliation in the publication record is Peking University, China.
How many publications and citations does Ye Shen have?
OpenAlex counts 52 works and 519 citations for Ye Shen, an h-index of 12, ranking #5,503,641 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ye Shen
- ye-shen-zhejiang-university
- ye-shen-university-of-georgia
- ye-shen-chinese-academy-of-medical-sciences-and-peking-union-medical-college
- ye-shen-california-polytechnic-state-university
- ye-shen-fudan-university
- ye-shen-pla-army-engineering-university
- ye-shen-henan-polytechnic-university
- ye-shen-university-of-alberta
- ye-shen-johns-hopkins-university
- ye-shen-technische-universitat-darmstadt
- ye-shen-tufts-university
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ye Shen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.